Skip to content

Organon – Ireland logo

Main menu
    • About Organon
      • Vision, mission & values
      • Diversity, equality & inclusion
    • Our leadership team
    • Environmental, social & governance
    • Our focus
    • Product list
    • Product supply updates
    • Media
    • Press releases
  • Join our team

Contact Us

Products list

Visit Organon's LinkedIn Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Please be advised that in accordance with the Irish Pharmaceutical Healthcare Association (IPHA) Code of Practice (click here to view the latest version), Organon is unable to correspond with or offer advice to members of the public on medical issues.  If you have a concern about your medical condition, please contact your Healthcare Professional directly for further information.

Here for her health

Why we're here

We believe in a better and healthier every day for every woman. And we understand that women are foundational to a healthier world. As a new company, we will begin by listening to women’s healthcare needs, big and small, enabling us to develop treatments tailored to them — because we know there is so much more we can do for women and their health.

Get to know us

Our areas of focus

We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. And we bring these important therapies around the world, with an international footprint that serves people in more than 140 markets.

Learn more about our focus areas

Women’s health

We know women need more choices when it comes to their healthcare. Through our portfolio of products specifically designed to address her needs, our goal is to create a better and healthier every day, for every woman.

Biosimilars

By providing access to biosimilars as an important treatment option, we aim to bring more choices to more patients who need them.

Established medicines

Our portfolio of established medicines has a long history and cover critical areas including cardiovascular, respiratory, dermatology and non-opioid pain management and more.

Previous
Next

Careers

Together, we work to address the healthcare issues that matter most to her

Our people – a global community of thousands strong – are united in our drive to better support the health of women within our company and around the globe.

Join our team

Leadership

Our leadership team

Find out more about our leadership team

Learn more

Media

Stay in the know

Keep up to date on all things Organon by checking out our latest news.

Read our latest news

Connect with us on social

Linkedin icon Opens a new window
Organon – Ireland logo

Company

  • About Organon
  • Environmental, social & governance
  • Our leadership team

Resources

  • Media

Contact us

  • Contact us
  • Cookie Policy
  • Privacy Policy
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept